Literature DB >> 23839026

Locomotor stimulant and discriminative stimulus effects of 'bath salt' cathinones.

Michael B Gatch1, Cynthia M Taylor, Michael J Forster.   

Abstract

A number of psychostimulant-like cathinone compounds are being sold as 'legal' alternatives to methamphetamine or cocaine. The purpose of these experiments was to determine whether cathinone compounds stimulate motor activity and have discriminative stimulus effects similar to those of cocaine and/or methamphetamine. 3,4-Methylenedioxypyrovalerone (MDPV), methylone, mephedrone, naphyrone, flephedrone, and butylone were tested for locomotor stimulant effects in mice and subsequently for substitution in rats trained to discriminate cocaine (10 mg/kg, intraperitoneally) or methamphetamine (1 mg/kg, intraperitoneally) from saline. All compounds fully substituted for the discriminative stimulus effects of cocaine and methamphetamine. Several commonly marketed cathinones produce discriminative stimulus effects comparable with those of cocaine and methamphetamine, which suggests that these compounds are likely to have similar abuse liabilities. MDPV and naphyrone produced locomotor stimulant effects that lasted much longer than those of cocaine or methamphetamine and therefore may be of particular concern, particularly because MDPV is one of the most commonly found substances associated with emergency room visits because of adverse effects of taking 'bath salts'.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23839026      PMCID: PMC4183201          DOI: 10.1097/FBP.0b013e328364166d

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  18 in total

1.  The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue.

Authors:  Michael H Baumann; Mario A Ayestas; John S Partilla; Jacqueline R Sink; Alexander T Shulgin; Paul F Daley; Simon D Brandt; Richard B Rothman; Arnold E Ruoho; Nicholas V Cozzi
Journal:  Neuropsychopharmacology       Date:  2011-12-14       Impact factor: 7.853

2.  4-Methylmethcathinone (mephedrone): neuropharmacological effects of a designer stimulant of abuse.

Authors:  Gregory C Hadlock; Katy M Webb; Lisa M McFadden; Pei Wen Chu; Jonathan D Ellis; Scott C Allen; David M Andrenyak; Paula L Vieira-Brock; Christopher L German; Kevin M Conrad; Amanda J Hoonakker; James W Gibb; Diana G Wilkins; Glen R Hanson; Annette E Fleckenstein
Journal:  J Pharmacol Exp Ther       Date:  2011-08-02       Impact factor: 4.030

3.  Clinical experience with and analytical confirmation of "bath salts" and "legal highs" (synthetic cathinones) in the United States.

Authors:  Henry A Spiller; Mark L Ryan; Robert G Weston; Joanne Jansen
Journal:  Clin Toxicol (Phila)       Date:  2011-07       Impact factor: 4.467

4.  Mephedrone, compared with MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and 5-HT levels in nucleus accumbens of awake rats.

Authors:  J Kehr; F Ichinose; S Yoshitake; M Goiny; T Sievertsson; F Nyberg; T Yoshitake
Journal:  Br J Pharmacol       Date:  2011-12       Impact factor: 8.739

5.  Comparative neuropharmacology of three psychostimulant cathinone derivatives: butylone, mephedrone and methylone.

Authors:  Raul López-Arnau; Jose Martínez-Clemente; David Pubill; Elena Escubedo; Jorge Camarasa
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

6.  Interaction of mephedrone with dopamine and serotonin targets in rats.

Authors:  José Martínez-Clemente; Elena Escubedo; David Pubill; Jorge Camarasa
Journal:  Eur Neuropsychopharmacol       Date:  2011-08-06       Impact factor: 4.600

7.  Mephedrone (4-methylmethcathinone, 'meow'): acute behavioural effects and distribution of Fos expression in adolescent rats.

Authors:  Craig P Motbey; Glenn E Hunt; Michael T Bowen; Suzanne Artiss; Iain S McGregor
Journal:  Addict Biol       Date:  2011-10-13       Impact factor: 4.280

8.  Mephedrone ('bath salt') elicits conditioned place preference and dopamine-sensitive motor activation.

Authors:  Renata Lisek; Wei Xu; Ekaterina Yuvasheva; Yi-Ting Chiu; Allen B Reitz; Lee-Yuan Liu-Chen; Scott M Rawls
Journal:  Drug Alcohol Depend       Date:  2012-05-29       Impact factor: 4.492

9.  Abuse liability profile of three substituted tryptamines.

Authors:  Michael B Gatch; Michael J Forster; Aaron Janowsky; Amy J Eshleman
Journal:  J Pharmacol Exp Ther       Date:  2011-04-07       Impact factor: 4.030

10.  Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.

Authors:  F Ivy Carroll; Bruce E Blough; Philip Abraham; Andrew C Mills; J Ashley Holleman; Scott A Wolckenhauer; Ann M Decker; Antonio Landavazo; K Timothy McElroy; Hernán A Navarro; Michael B Gatch; Michael J Forster
Journal:  J Med Chem       Date:  2009-11-12       Impact factor: 7.446

View more
  94 in total

1.  Reinforcing and neurochemical effects of the "bath salts" constituents 3,4-methylenedioxypyrovalerone (MDPV) and 3,4-methylenedioxy-N-methylcathinone (methylone) in male rats.

Authors:  Charles W Schindler; Eric B Thorndike; Steven R Goldberg; Kurt R Lehner; Nicholas V Cozzi; Simon D Brandt; Michael H Baumann
Journal:  Psychopharmacology (Berl)       Date:  2015-08-29       Impact factor: 4.530

2.  Mephedrone interactions with cocaine: prior exposure to the 'bath salt' constituent enhances cocaine-induced locomotor activation in rats.

Authors:  Ryan A Gregg; Christopher S Tallarida; Allen B Reitz; Scott M Rawls
Journal:  Behav Pharmacol       Date:  2013-12       Impact factor: 2.293

3.  Locomotor Stimulant and Rewarding Effects of Inhaling Methamphetamine, MDPV, and Mephedrone via Electronic Cigarette-Type Technology.

Authors:  Jacques D Nguyen; Shawn M Aarde; Maury Cole; Sophia A Vandewater; Yanabel Grant; Michael A Taffe
Journal:  Neuropsychopharmacology       Date:  2016-06-09       Impact factor: 7.853

4.  Comparative Behavioral Pharmacology of Three Pyrrolidine-Containing Synthetic Cathinone Derivatives.

Authors:  Michael B Gatch; Sean B Dolan; Michael J Forster
Journal:  J Pharmacol Exp Ther       Date:  2015-05-21       Impact factor: 4.030

5.  Investigation of "bath salts" use patterns within an online sample of users in the United States.

Authors:  Patrick S Johnson; Matthew W Johnson
Journal:  J Psychoactive Drugs       Date:  2014 Nov-Dec

6.  Δ9-Tetrahydrocannabinol-like discriminative stimulus effects of compounds commonly found in K2/Spice.

Authors:  Michael B Gatch; Michael J Forster
Journal:  Behav Pharmacol       Date:  2014-12       Impact factor: 2.293

7.  Effects of orally self-administered bath salt constituent 3,4-methylenedioxypyrovalerone (MDPV) in mice.

Authors:  Brenda M Gannon; Lauren N Russell; Meet S Modi; Kenner C Rice; William E Fantegrossi
Journal:  Drug Alcohol Depend       Date:  2017-08-04       Impact factor: 4.492

8.  Discriminative stimulus and locomotor effects of para-substituted and benzofuran analogs of amphetamine.

Authors:  Sean B Dolan; Michael J Forster; Michael B Gatch
Journal:  Drug Alcohol Depend       Date:  2017-08-24       Impact factor: 4.492

9.  Stereochemistry and neuropharmacology of a 'bath salt' cathinone: S-enantiomer of mephedrone reduces cocaine-induced reward and withdrawal in invertebrates.

Authors:  Alexandre Vouga; Ryan A Gregg; Maryah Haidery; Anita Ramnath; Hassan K Al-Hassani; Christopher S Tallarida; David Grizzanti; Robert B Raffa; Garry R Smith; Allen B Reitz; Scott M Rawls
Journal:  Neuropharmacology       Date:  2014-12-09       Impact factor: 5.250

10.  Abuse liability of the dietary supplement dimethylamylamine.

Authors:  Sean B Dolan; Michael B Gatch
Journal:  Drug Alcohol Depend       Date:  2014-11-25       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.